The Allahabad High Court overturned the cancellation of Marion Biotech’s drug manufacturing licence following 15 child deaths in Uzbekistan. It criticized Indian authorities for relying on a foreign court’s judgment and emphasized the need for domestic legal procedures. This ruling highlights procedural concerns and may influence future regulatory actions regarding Indian companies abroad.
